Event Details
Dates: October 7 to 9, 2026
Location: New York Athletic Club, 180 Central Park S, New York, New York
Event Website: https://avbcc.org/avbcc-2026/
Event Overview
Cizzle Bio will attend the 2026 AVBCC Summit, an invitation-only forum bringing together leaders and decision-makers from across the oncology ecosystem to address the evolving challenges of delivering high-quality, sustainable, and value-based cancer care.
Hosted by the Association for Value-Based Cancer Care (AVBCC), the summit creates an environment for high-level discussion, education, and trusted networking among stakeholders working across cancer care.
Programming addresses key areas influencing the oncology landscape, including health policy, reimbursement, practice management, oncology specialty pharmacy, patient access, and value-based care. The summit is designed to encourage practical dialogue and collaboration among leaders navigating the changing clinical, operational, and economic realities of cancer care.
Why Attend
Engage with oncology leaders and decision-makers from across the cancer care ecosystem.
Explore developments in health policy, reimbursement, and value-based cancer care.
Gain perspectives on practice management, patient access, and oncology specialty pharmacy.
Participate in high-level networking and conversations focused on improving quality and sustainability in cancer care.
Cizzle Bio's Focus
As a company advancing biomarker blood tests for early cancer detection, Cizzle Bio recognizes that improving cancer outcomes requires innovation not only in diagnostics, but also in how new technologies are integrated into the broader healthcare system.
Attending the 2026 AVBCC Summit supports our commitment to understanding the clinical, operational, policy, and access considerations shaping modern oncology. Engaging with leaders across the cancer care ecosystem helps inform the broader conversation around earlier detection, patient access, diagnostic innovation, and value-driven cancer care.